UK Markets open in 5 hrs 34 mins

Senseonics Holdings, Inc. (SENS)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
1.1500+0.0300 (+2.68%)
At close: 04:00PM EST
1.1500 0.00 (0.00%)
After hours: 07:51PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.1200
Open1.1200
Bid1.1300 x 1300
Ask1.1500 x 1200
Day's range1.1000 - 1.1500
52-week range0.7700 - 3.8900
Volume2,127,040
Avg. volume2,705,825
Market cap549.994M
Beta (5Y monthly)0.96
PE ratio (TTM)N/A
EPS (TTM)-0.7690
Earnings date27 Feb 2023 - 03 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.10
  • Business Wire

    Senseonics Announces Equity Grants To Employees Under Inducement Plan

    GERMANTOWN, Md., January 05, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it had made equity grants to new employees under its 2019 Inducement Plan (the "Plan") in accordance with NYSE American Company Guide Section 711(a).

  • Business Wire

    Senseonics to Present at the Stifel 2022 Healthcare Conference

    GERMANTOWN, Md., November 09, 2022--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel Healthcare Conference in New York, NY.

  • Business Wire

    Senseonics Holdings, Inc. Reports Third Quarter 2022 Financial Results

    GERMANTOWN, Md., November 08, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended September 30, 2022.